Opioid Abuse: The Limits Of Industry’s Response

 
• By Michael McCaughan

PhRMA is endorsing dispensing limits on opioids and pledging to support a public/private partnership to develop new treatments and alternatives. But members of a Presidential Commission didn’t seem impressed.

Hitting bigger business target
PhRMA feels its pledge is hitting a big target; policymakers may have bigger ideas.

More from Marketing & Advertising

More from Compliance